Debt down & cash is king
06/12/23 -"Fresenius has decided to accept the €300m (of which ~70m had already been taken) from the German government, which is the relief package to compensate for the additional costs caused by the increase ..."
Pages
57
Language
English
Published on
06/12/23
You may also be interested by these reports :
08/05/25
Qiagen commenced 2025 positively, with robust performance in Diagnostic Solutions and PCR/Nucleic Acid Amplification, although this was partially ...
08/05/25
Demant’s Q1 results met market expectations. Growth in Hearing Care was counterbalanced by weakness in Hearing Aids. Meanwhile, Diagnostics remained ...
07/05/25
DiaSorin’s Q1 results marginally surpassed market expectations, demonstrating good performance across all segments. Profitability improved and ...
07/05/25
Q2 figures exceeded expectations, surpassing consensus estimates (sales: +2.0%; adjusted EBIT: +4.4%). This was primarily due to pre-buying ...